BioWorld MedTech

April 7, 2011

Emerge sees a need for line of generic orthopedic devices

A new medical device company has emerged with the goal of targeting the $2 billion orthopedic trauma market with the industry's first line of high-quality generic implants and instruments. (Medical Device Daily) Read More

VisualSonics developing new photoacoustics imaging tool

International report: Volcano cleared to market PrimeWire Prestige in Japan

Shuren says start date of new harmonization body uncertain

Deals roundup: LabCorp to acquire OC shares for $85 million

MDD's food for med-tech thought

Agreements/contracts: GE partners with TomTec to 'enhance patient care'

Court Report: Hospital to pay $1.9M to settle Medicare fraud charges

Med-Tech Notes

Product Briefs

People in the News

MDD's Ortho Extra

Today's news in brief

BioWorld

BioWorld briefs for Jan 16, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 16, 2026.

Illustration of human body surrounded by DNA, cell and drug icons

Cell/gene therapy sector now sustainable; China competition mounting

BioWorld

There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...

Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal

BioWorld

With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...

DNA mutations or genetic disorder concept art

Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease

BioWorld Science

Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...